Imunon, Inc. Common Stock
IMNN
IMNN: Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
moreShow IMNN Financials
Recent trades of IMNN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IMNN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on IMNN's company Twitter account
Number of mentions of IMNN in WallStreetBets Daily Discussion
Recent insights relating to IMNN
Recent picks made for IMNN stock on CNBC
ETFs with the largest estimated holdings in IMNN
Flights by private jets registered to IMNN